NCT05749146 · ACTIVE NOT RECRUITING
Palliative Care for Patients With Dementia
This trial is testing whether a structured in-home palliative care program improves quality of life and comfort for people with advanced dementia and their family caregivers. Participants are randomly assigned to either the home palliative care program or a standard enhanced care group. This is a Phase NA trial, meaning it is evaluating real-world effectiveness of a care delivery model, not a drug or device.
You may qualify if
- have advanced dementia, based on Global Deterioration Score (GDS)>6
- impairment in at least one activity of daily living (ADL -which is inherent in this level of GDS)
- at least one hospitalization or ED visit within the last 12 months
- a physician who is primarily responsible for their dementia-related care whose clinical outpatient site is associated with one of the four Mount Sinai sites in Manhattan
- a family caregiver willing to enroll
- a residence in Manhattan where they are currently living (not in a long-term care facility)
- capacity to consent or a legal representative available to provide consent
- fluency in English or Spanish, or their legal representative must be fluent in English or Spanish
- age >64.
You're excluded if
- Does not have a family caregiver to enroll
- Does not reside in Manhattan outside of long-term care facility
- Does not have fluency in English or Spanish Doesn't
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-22